News tagged with breast cancer cells
Related topics: breast cancer , cancer cells , cells , tumor cells , breast cancer patients
(HealthDay) -- Perjeta (pertuzumab) has been approved by the U.S. Food and Drug Administration to treat people with HER2-positive late-stage breast cancer, the agency said in a news release.
Cancer Jun 11, 2012 | not rated yet | 0
Presence of normal p53, a tumor suppressor gene, instead of a mutated version, makes breast cancer chemotherapy with doxorubicin less effective. The preclinical study led by MD Anderson scientists was published today in the ...
Cancer Jun 11, 2012 | not rated yet | 0 |
ADAM28, a metalloproteinase belonging to the ADAM gene family, cleaves the von Willebrand factor (VWF) and inhibits VWF-mediated cancer cell apoptosis, thereby enhancing lung metastases, so inhibiting its expression gives ...
Cancer Jun 08, 2012 | not rated yet | 0 |
Breast cancer, a double mastectomy and kidney cancer - in all, nine surgeries in three years - left Kathleen Bindyke feeling like a battered warrior. But she decided to put herself into better shape than when the ordeal began.
Cancer Jun 08, 2012 | 5 / 5 (1) | 0
The HIV drugs known as CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing, researchers from the Kimmel Cancer Center at Jefferson suggest in a preclinical study published in a recent issue ...
Cancer Jun 06, 2012 | not rated yet | 0 |
Scientists have discovered that a simple blood test could lead to better diagnosis and treatment for early-stage breast cancer patients, according to an Article published Online First in The Lancet Oncology.
Cancer Jun 05, 2012 | not rated yet | 0
(Medical Xpress) -- Stem cells often used in reconstructive surgery following mastectomies and other cancer-removal treatments may pose a danger: Cornell biomedical scientists have discovered that these cells, ...
Cancer Jun 05, 2012 | 5 / 5 (1) | 0
Inflammatory breast cancer is a very aggressive type of cancer associated with early metastasis and poor survival rates, and the prognosis is even worse for patients with tumors expressing the ErbB2 receptor. The ErbB2-inhibiting ...
Cancer Jun 01, 2012 | not rated yet | 0
New research from the University of Wisconsin-Madison explains why the incurable brain cancer, glioblastoma multiforme (GBM), is highly resistant to current chemotherapies.
Cancer Jun 01, 2012 | 4.5 / 5 (2) | 0 |
Researchers at Clarkson University in Potsdam, N.Y., led by Chemistry & Biomolecular Science Professor Costel C. Darie, in collaboration with researchers from Columbia University, have now found the binding partner of TDF, ...
Cancer Jun 01, 2012 | 5 / 5 (1) | 0
The 20 proteins in the Wnt family are some of the most important proteins in controlling how an organism develops and grows, but for 30 years scientists have not known what these vital proteins actually look ...
Medical research May 31, 2012 | 5 / 5 (2) | 0 |
Breast-cancer researchers at the University of Wisconsin-Madison have found that two related receptors in a robust signaling pathway must work together as a team to maintain normal activity in mammary stem cells.
Cancer May 30, 2012 | not rated yet | 0 |
(HealthDay) -- Women who work the night shift more than twice a week might be increasing their risk for breast cancer, Danish researchers find.
Health May 29, 2012 | 5 / 5 (1) | 0 |
HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.
Cancer May 25, 2012 | not rated yet | 0 |